Publications

Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.

ZHENG, B; Tazare, J; Nab, L; Green, AC; Curtis, HJ; MAHALINGASIVAM, V; HERRETT, EL; COSTELLO, RE; EGGO, RM; Speed, V; Bacon, SC; Bates, C; Parry, J; Cockburn, J; Hester, F; Harper, S; Schaffer, AL; Hulme, WJ; Mehrkar, A; EVANS, SJ; MacKenna, B; GOLDACRE, B; DOUGLAS, IJ; TOMLINSON, LA; OpenSAFELY Collaborative,;

2023

The Lancet Regional Health - Europe, (2023).34, 10.1016/j.lanepe.2023.100741.

Asymptomatic but infectious - The silent driver of pathogen transmission. A pragmatic review.

SHAIKH, N; Swali, P; HOUBEN, RM G J;

2023

Epidemics, (2023).44, 10.1016/j.epidem.2023.100704.

Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis.

Choi, HC W; Leung, K; Chan, KK L; Bai, Y; JIT, M; Wu, JT;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02748-3.

Decision-support tools to build climate resilience against emerging infectious diseases in Europe and beyond.

Rocklöv, J; Semenza, JC; Dasgupta, S; Robinson, EJ Z; Abd El Wahed, A; Alcayna, T; Arnés-Sanz, C; Bailey, M; Bärnighausen, T; Bartumeus, F; Borrell, C; Bouwer, LM; Bretonnière, P-A; Bunker, A; Chavardes, C; Van Daalen, KR; Encarnação, J; González-Reviriego, N; Guo, J; Johnson, K; Koopmans, MP G; Máñez Costa, M; Michaelakis, A; Montalvo, T; Omazic, A; ... LOWE, R.

2023

The Lancet regional health. Europe, (2023).32, 10.1016/j.lanepe.2023.100701.

Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle.

ATKINS, KE; HODGSON, D;

2023

Clinical infectious diseases, (2023).77 3 10.1093/cid/ciad162.

epiforecasts/ringbp.

ABBOTT, S; Hellewell, J; Lucas, T; FUNK, S; Gimma, A;

2023

, Zenodo (2023).

The macroeconomic and epidemiological impacts of Covid-19 in Pakistan.

JENSEN, HT; KEOGH-BROWN, M; EGGO, R; PEARSON, C; TORRES-RUEDA, S; Huda, M; Khalid, M; Zulfiqar, W; Smith, R; JIT, M; VASSALL, A; CMMID COVID-19 Working Group,;

2023

medRxiv (2023). 10.1101/2023.10.06.23296657.

First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY.

Hopcroft, LE; Curtis, HJ; Brown, AD; Hulme, WJ; Andrews, CD; Morton, CE; Inglesby, P; Morley, J; Mehrkar, A; Bacon, SC; EGGO, RM; MAHALINGASIVAM, V; Parker, EP K; TOMLINSON, LA; Bates, C; Cockburn, J; Parry, J; Hester, F; Harper, S; GOLDACRE, B; Walker, AJ; MacKenna, B;

2023

Wellcome open research, (2023).8, 10.12688/wellcomeopenres.18735.2.

yangclaraliu/covid_vac_africa: BMCMed_R3.

LIU, Y; PROCTER, SR; PEARSON, CA B; MADRIZ MONTERO, A; TORRES-RUEDA, S; Asfaw, E; Uzochukwu, B; Drake, T; Bergren, E; EGGO, RM; Ruiz, F; Ndembi, N; Nonvignon, J; JIT, M; VASSALL, A;

2023

, Zenodo (2023).

Collaborative nowcasting of COVID-19 hospitalization incidences in Germany.

Wolffram, D; ABBOTT, S; An der Heiden, M; FUNK, S; Günther, F; Hailer, D; Heyder, S; Hotz, T; Van de Kassteele, J; Küchenhoff, H; Müller-Hansen, S; Syliqi, D; Ullrich, A; Weigert, M; Schienle, M; Bracher, J;

2023

Cold Spring Harbor Laboratory (2023). 10.1101/2023.04.17.23288668.